Under construction, not live – Unidade Local de Saúde Santa Maria: trials and research groups

Running trials

Not yet recruiting
Family-centred Pulmonary Rehabilitation to Empower Carers
NCT07791147· Aveiro University· Source
Recruiting
Specific Immunotherapy With Mannan-Conjugated Allergoids for HDM-Allergic Rhinitis/Rhinoconjunctivitis. MM09-SIT-063.
NCT07904052· Phase 3· Inmunotek S.L.· Source
Recruiting
Cardiac Remodelling Following Endovascular Repair of the Aorta
NCT07415447· Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa· Source
Recruiting
Early Doppler-Assisted Mobilization in Adults After Acute Ischemic Stroke
NCT07232498· Unidade Local de Saúde de Coimbra, EPE· Source
Not yet recruiting
Urban and Insular Study on Treatment Experiences and Stigma in People Living with HIV
NCT06812910· Fábio Cota Medeiros· Source
Enrolling by invitation
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
NCT06908226· Phase 3· Longboard Pharmaceuticals· Source
Enrolling by invitation
Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM)
NCT06862479· Unidade Local de Saúde Santa Maria· Source
Active, not recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)
NCT06719141· Phase 3· Longboard Pharmaceuticals· Source
Active, not recruiting
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394· Phase 3· Longboard Pharmaceuticals· Source
Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
NCT06056297· Phase 3· X4 Pharmaceuticals· Source
Recruiting
Global Research Initiative for Patients Screening on MASH
NCT05651724· Julius Clinical· Source
Recruiting
The Triad of Nutrition, Intestinal Microbiota and Rheumatoid Arthritis (TASTY)
NCT06758817· Lisbon Academic Medical Center - Centro Académico de Medicina de Lisboa· Source
Active, not recruiting
An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
NCT05494606· AbbVie· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Asthma2 recruiting
Obesity2 recruiting
Bronchiectasis1 recruiting
COPD1 recruiting
Epilepsy1 recruiting
Fatty liver disease (MASLD/MASH)1 recruiting
Gastric and oesophageal cancer1 recruiting
Heart failure1 recruiting
High blood pressure1 recruiting
HIV1 recruiting
Lung cancer1 recruiting
Rheumatoid arthritis1 recruiting
Stroke1 recruiting
Type 2 diabetes1 recruiting

Closed trials

Completed
A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
NCT03104374· Phase 3· AbbVie· Source

Trial sites

Conditions

Diseases this institution publishes on or runs trials for.

Amyloidosis13 works · 0 trials
Sjögren's disease4 works · 0 trials